0001677300-16-000002.txt : 20160621 0001677300-16-000002.hdr.sgml : 20160621 20160621192231 ACCESSION NUMBER: 0001677300-16-000002 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160614 FILED AS OF DATE: 20160621 DATE AS OF CHANGE: 20160621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KARABELAS ARGERIS N CENTRAL INDEX KEY: 0001191229 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 161725402 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2016-06-14 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001191229 KARABELAS ARGERIS N 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 0 0 0 No Securities beneficially owned. 0 D No Derivative Securities beneficially owned. No Derivative Securities beneficially owned. 0 D No Securities beneficially owned. Robert Chai-Onn for Argeris N. Karabelas 2016-06-21